Back
Allogene Therapeutics 10K Form
Sell
34
ALLO
Allogene Therapeutics
Last Price:
$1.24
Seasonality Move:
-16.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALLO News And Ratings
See the #1 stock for the next 7 days that we like better than ALLO
ALLO Financial Statistics
Sales & Book Value
| Annual Sales: | $22K |
|---|---|
| Cash Flow: | $-53M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.76 |
| Price / Book: | 0.7 |
Profitability
| EPS (TTM): | -1.23000 |
|---|---|
| Net Income (TTM): | $-252.3M |
| Gross Margin: | -- |
| Return on Equity: | -52.73% |
| Return on Assets: | -42.25% |
Allogene Therapeutics Earnings Forecast
Key Allogene Therapeutics Financial Ratios
-
The Research & Development expenses have been 874,086.36% of Revenue.
-
The Net Earning history of ALLO is -1,170,863.64% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 4 years.
Allogene Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALLO |
| CUSIP: | 019770 |
| Website: | allogene.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.8 |
| Quick Ratio: | 12.46 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALLO Technical Analysis vs Fundamental Analysis
Sell
34
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a SellThe current Allogene Therapeutics [ALLO] share price is $1.23. The Score for ALLO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.